ÂÜÀòÂÒÂ×

Duane Sword is a Co-Founder and Chief Business Officer of CytoTronics, where they focus on commercializing innovative technologies emerging from Harvard University labs in drug discovery. They currently serve as a Strategic Advisor at Cerno Bioscience and a Board Member at Sensmet Ltd, both of which enhance analytical performance in various scientific fields. With a strong background in sales and marketing, Duane has held leadership positions at notable companies including Ahura Scientific and Thermo Fisher Scientific, contributing to the growth of advanced analytical solutions. Duane's academic credentials include a Bachelor of Science from RMIT University and participation in programs at the Massachusetts Institute of Technology.